Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

Market Cap	10.66B +2.6%
Revenue (ttm)	5.22B +8.7%
Net Income	172.92M +2.0%
EPS	0.23 +4.7%
Shares Out	760.85M
PE Ratio	60.38
Forward PE	93.40
Dividend	0.06 (0.43%)
Ex-Dividend Date	Sep 25, 2025

Volume	5,702,047
Average Volume	9,597,456
Open	15.09
Previous Close	14.01
Day's Range	13.80 - 15.09
52-Week Range	10.60 - 20.37
Beta	0.40
RSI	31.00
Earnings Date	Apr 29, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 5,417
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300171

Financial Performance

In 2024, SHE:300171's revenue was 5.01 billion, a decrease of -11.19% compared to the previous year's 5.64 billion. Earnings were 194.09 million, a decrease of -67.66%.